HI Detection in two Dwarf S0 Galaxies in Nearby Groups: ESO384-016 and NGC 59

An \hi survey of 10 dE/dS0 galaxies in the nearby Sculptor and Centaurus A groups was made using the Australia Telescope Compact Array (ATCA). The observed galaxies have accurate distances derived by Jerjen et al (1998; 2000b) using the surface brightness fluctuation technique. Their absolute magnitudes are in the range $-9.5 > M_B > -15.3$. Only two of the ten galaxies were detected at our detection limit ($\sim 1.0 \times 10^6$ \msol for the Centaurus group and $\sim 5.3 \times 10^5$ \msol for the Sculptor group), the two dS0 galaxies ESO384-016 in the Centaurus A Group and NGC 59 in the Sculptor Group, with \hi masses of $6.0 \pm 0.5 \times 10^6$ \msol and $1.4 \pm 0.1 \times 10^7$ \msol respectively. Those two detections were confirmed using the Green Bank Telescope. These small \hi reservoirs could fuel future generations of low level star formation and could explain the bluer colors seen at the center of the detected galaxies. Similarly to what is seen with the Virgo dEs, the two objects with \hi appear to be on the outskirt of the groups.Comment: 25 pages (11 figures), accepted by A

UNDERSTANDING THE DIFFICULTIES HINDERING INTER-AGENCY COLLABORATION FOR STUDENTS WITH SPECIAL NEEDS IN QUEBEC

In 2003, the government of Quebec established the Agreement for the Complementarity of Services Between the Health and Social Services Network and the Education Network to define principles and obligations for inter- agency collaboration aimed at students with special needs and their families. This study documents the perspectives of organisation members from both networks. One hundred eighty-one participants were interviewed regarding their perceptions of inter-agency collaboration and related difficulties. Findings reveal that although network members are committed to collaborate in concordance with the Agreement, significant obstacles hinder an effective partnership, including an overall lack of coherence and gaps in the conditions required for an effective partnership, as well as insufficient awareness of the Agreement.

The Recent Star Formation History of NGC 5102

We present Hubble Space Telescope photometry of young stars in NGC 5102, a nearby gas-rich post-starburst S0 galaxy with a bright young stellar nucleus. We use the IAC-pop/MinnIAC algorithm to derive the recent star formation history in three fields in the bulge and disk of NGC 5102. In the disk fields, the recent star formation rate has declined monotonically and is now barely detectable, but a starburst is still in progress in the bulge and has added about 2 percent to the mass of the bulge over the last 200 Myr. Other studies of star formation in NGC 5102 indicate that about 20 percent of its stellar mass was added over the past Gyr. If this is correct, then much of the stellar mass of the bulge may have formed over this period. It seems likely that this star formation was fueled by the accretion of a gas-rich system with HI mass of about 2 x 10^9 Msol which has now been almost completely converted into stars. The large mass of recently formed stars and the blue colours of the bulge suggest that the current starburst, which is now fading, may have made a significant contribution to build the bulge of NGC 5102.Comment: 36 pages, 16 figures, accepted in A

Expression of CD33 is a predictive factor for effect of gemtuzumab ozogamicin at different doses in adult acute myeloid leukaemia

It remains unclear in adult acute myeloid leukaemia (AML) whether leukaemic expression of CD33, the target antigen for gemtuzumab ozogamicin (GO), adds prognostic information on GO effectiveness at different doses. CD33 expression quantified in 1583 patients recruited to UK-NCRI-AML17 (younger adults) and UK-NCRI-AML16 (older adults) trials was correlated with clinical outcomes and benefit from GO including a dose randomisation. CD33 expression associated with genetic subgroups, including lower levels in both adverse karyotype and core-binding factor (CBF)-AML, but was not independently prognostic. When comparing GO versus no GO (n=393, CBF-AMLs excluded) by stratified subgroup-adjusted analysis, patients with lowest quartile (Q1) Í33-positivity had no benefit from GO (relapse risk, HR 2.41 (1.27–4.56), P=0.009 for trend; overall survival, HR 1.52 (0.92–2.52)). However, from the dose randomisation (NCRI-AML17, n=464, CBF-AMLs included), 6 mg/m2 GO only had a relapse benefit without increased early mortality in CD33-low (Q1) patients (relapse risk HR 0.64 (0.36–1.12) versus 1.70 (0.99–2.92) for CD33-high, P=0.007 for trend). Thus CD33 expression is a predictive factor for GO effect in adult AML; although GO does not appear to benefit the non-CBF AML patients with lowest CD33 expression a higher GO dose may be more effective for CD33-low but not CD33-high younger adults

Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDS

Allogeneic stem-cell transplant allows for the delivery of curative graft-versus-leukemia (GVL) in patients with acute myeloid leukemia/myelodysplasia (AML/MDS). Surveillance of T-cell chimerism, measurable residual disease (MRD) and blast HLA-DR expression may inform whether GVL effectiveness is reduced. We report here the prognostic impact of these biomarkers in patients allografted for AML/MDS. One hundred eighty-seven patients from FIGARO, a randomized trial of reduced-intensity conditioning regimens in AML/MDS, were alive and relapse-free at the first MRD time-point and provided monitoring samples for flow cytometric MRD and T-cell chimerism, requested to month+12. Twenty-nine (15.5%) patients had at least 1 MRD-positive result posttransplant. MRD-positivity was associated with reduced overall survival (OS) (hazard ratio [HR], 2.18; P = .0028) as a time-varying Cox variable and remained significant irrespective of pretransplant MRD status in multivariate analyses (P < .001). Ninety-four patients had sequential MRD with T-cell chimerism results at months+3/+6. Patients with full donor T-cell chimerism (FDTC) had an improved OS as compared with patients with mixed donor T-cell chimerism (MDTC) (adjusted HR=0.4; P = .0019). In patients with MDTC (month+3 or +6), MRD-positivity was associated with a decreased 2-year OS (34.3%) vs MRD-negativity (71.4%) (P = .001). In contrast, in the group with FDTC, MRD was infrequent and did not affect the outcome. Among patients with posttransplant MRD-positivity, decreased HLA-DR expression on blasts significantly reduced OS, supporting this as a mechanism for GVL escape. In conclusion, posttransplant MRD is an important predictor of the outcome in patients allografted for AML/MDS and is most informative when combined with T-cell chimerism results, underlining the importance of a GVL effect in AML/MDS

Lipotoxicity in obese pregnancy and its potential role in adverse pregnancy outcome and obesity in the offspring

Increasing maternal obesity is a challenge that has an impact on all aspects of female reproduction. Lean and obese pregnant women gain similar fat mass, but lean women store fat in the lower-body compartment and obese women in central compartments. In the non-pregnant, central storage of fat is associated with adipocyte hypertrophy and represents a failure to adequately store excess fatty acids, resulting in metabolic dysregulation and ectopic fat accumulation (lipotoxicity). Obese pregnancy is associated with exaggerated metabolic adaptation, endothelial dysfunction and increased risk of adverse pregnancy outcome. We hypothesize that the preferential storage of fat in central rather than ‘safer’ lower-body depots in obese pregnancy leads to lipotoxicity. The combination of excess fatty acids and oxidative stress leads to the production of oxidized lipids, which can be cytotoxic and influence gene expression by acting as ligands for nuclear receptors. Lipid excess and oxidative stress provoke endothelial dysfunction. Oxidized lipids can inhibit trophoblast invasion and influence placental development, lipid metabolism and transport and can also affect fetal developmental pathways. As lipotoxicity has the capability of influencing both maternal endothelial function and placental function, it may link maternal obesity and placentally related adverse pregnancy outcomes such as miscarriage and pre-eclampsia. The combination of excess/altered lipid nutrient supply, suboptimal in utero metabolic environment and alterations in placental gene expression, inflammation and metabolism may also induce obesity in the offspring